PTC Therapeutics (PTCT) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
CEO welcomed attendees, introduced board members, and outlined the meeting agenda and rules of conduct.
The meeting was confirmed as duly called with a quorum present, and the record date and notice procedures were established.
Board and executive committee updates
Four Class II director nominees were presented for election to serve until 2027, with no other nominations made.
Shareholder proposals
Proposals included electing four directors, ratifying the appointment of the independent auditor, and an advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from PTC Therapeutics
- Sephience drives robust growth and pipeline expansion, with strong launch momentum and broad R&D progress.PTCT
Leerink Global Healthcare Conference 202624 Mar 2026 - Sepiapterin’s rapid global launch drives strong PKU adoption and robust pipeline momentum.PTCT
Barclays 28th Annual Global Healthcare Conference20 Mar 2026 - Sephience's launch accelerates growth, with pipeline and global expansion fueling future momentum.PTCT
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Surpassed 2025 revenue targets and set ambitious 2026 growth and R&D milestones.PTCT
Corporate presentation27 Feb 2026 - 2025 revenue and net income soared on Sephience's launch and Novartis deal; 2026 growth expected.PTCT
Q4 202520 Feb 2026 - Four FDA filings, $814M revenue, and major 2025 launches drive growth and innovation.PTCT
43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026 - PTC518 showed robust, durable mHTT lowering, slowed symptoms, and strong safety at 12 months.PTCT
Study Result3 Feb 2026 - Q2 2024 revenue was $186.7M–$187M, net loss narrowed, and cash reserves reached $1.09B.PTCT
Q2 20242 Feb 2026 - Operational focus, strong pipeline, and regulatory progress position for future growth.PTCT
The 44th Annual William Blair Growth Stock Conference31 Jan 2026